3rd Immune dysregulation workshop Barcelona: From basics to clinics to advanced therapies
A FOCIS Center of Excellence initiative (CIS-UB) bringing together leading experts to advance immune health
FOCIS Center of Excellence CIS-UB: Leading Innovation in Immunology
The CIS-UB (Clínic for Immunology along Sant Joan de Déu in University of Barcelona) is a joint initiative bringing together Hospital Sant Joan de Déu Barcelona, Spain’s leading pediatric hospital; Hospital Clínic de Barcelona, a national reference center for adult care; and the University of Barcelona, a top institution in biomedical teaching and research.
This strategic collaboration integrates patient care, research, and education to advance the diagnosis and treatment of immunological diseases in both children and adults. Through shared units and laboratories, the development of advanced therapies, and participation in international networks, CIS-UB strengthens Barcelona’s position as a hub for immunotherapy, transplantation, autoimmune disorders, and immunodeficiencies, while also training the next generation of specialists and researchers.
A strategic alliance
Shaping the future of Immune Dysregulation
The 3rd Immune Dysregulation Workshop will gather leading international experts in a unique forum to share the latest breakthroughs in understanding, diagnosing, and treating immune dysregulation disorders.
Across three dynamic days, participants will explore advances ranging from the foundations of immune regulation to innovative therapies such as Treg-based strategies, thymic transplantation, gene therapy, CAR-T approaches in pediatric and autoimmune diseases, and new frontiers in GMP-based advanced therapy manufacturing.
An inspiring space where science and clinical innovation converge to transform patient care.
At the end of this training you will be able to:
- Understand and highlight the most recent advances in immune dysregulation, spanning from basic mechanisms to clinical applications.
- Explore and discuss innovative therapeutic strategies, including Treg-based approaches, gene therapy, and CAR-T in autoimmune and pediatric diseases.
- Exchange knowledge and foster collaboration between international clinicians and researchers.
- Apply practical insights into the development and manufacturing of advanced therapies in GMP settings.
Improve your skills in:
Contents:
Wednesday 17th December.
Location: Tau room at CosmoCaixa
Table 1:
Advances in mechanisms underlying immune dysregulatory diseases.
Rubén Barricarte, PhD. Vanderbilt University and Hospital Sant Joan de Déu Barcelona.
Marieke Lavaert, PhD. National Institute of Allergy and Infectious Diseases, NIH, Bethesda.
Andrea Cerutti, MD/PhD. IMIM. Barcelona
Table 2:
Advances in treatment in immune dysregulatory diseases.
Rafael Correa, PhD. Laboratory of Immune-Regulation, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Alexandra Kreins, MD. University College London, London.
Daniel Acevedo-Gomez, MsC. Hospital Sant Joan de Deu.
Virginia Pascual, MD/PhD. Gale and Ira Drukier Director of Children's Health Research, Weill Cornell Medical College. New York.
Thursday 18th December.
Location: Agora room at CosmoCaixa
Table 3:
Gene therapy and preclinical studies.
Anna Villa, MD/PhD. San Rafaelle. Milan.
Alessandra Magnani, MD/PhD. Hospital Sant Joan de Deu. Barcelona.
Hugo Calderón, PhD. Hospital Clínic de Barcelona, Barcelona.
Juan Bueren, PhD. CIEMAT. Madrid.
Table 4:
CAR-T therapies.
Carola García Vinuesa, MD/PhD. The Francis Crick Institute, London.
Concetta Quintarelli, PhD. Gene Therapy Lab, Ospedale Bambino Gesù, Rome.
Lorena Perez, PhD. CaixaResearh Institute for Immunology. Barcelona.
Julio Delgado, MD/PhD. Hospital Clinic de Barcelona, Barcelona.
H.U. Scherer, University of Leiden, Leiden.
Friday 19th December. Technical workshop in ATMP manufacturing.
Location: Advanced Therapies Platform SJD-Clinic (Sala Pasteur). SJD Barcelona Children's Hospital
Julio Castaño, PhD & Raquel Cabezon, PhD. Joint Platform for ATMPs HCB-HSJD.
Daniel Benitez, PhD & E. Azucena Gonzalez, PhD. Joint Platform for ATMPs HSJD- HCB.
Aimed at:
- Physicians (immunologists, pediatricians, hematologists, rheumatologists).
- Clinical researchers and translational scientists.
- Laboratory specialists in immunology and advanced therapies.
- Residents, fellows, and PhD students in related fields.
- Professionals involved in cell and gene therapy development.
Learning experience
We have designed a complete program, carefully prepared with the participation of expert speakers to guarantee you a high-level training experience.
The event is available both in person and online, giving you the flexibility to choose how to participate.
If you choose the online edition, you will need to connect live.
The webinar link will be sent 24 hours before the start of the course.
Learn with international leaders in the specialty, who will share their knowledge and experience in each session.
The program provides spaces for sharing experiences and networking among the participants.
To obtain the certificate, you will be asked to complete a satisfaction survey in the virtual classroom.
Location
The workshop will be hosted in two emblematic venues in Barcelona.
December 17th & 18th
Tau and Agora room at CosmoCaixa
CosmoCaixa
Carrer d'Isaac Newton, 26
Distrito de Sarrià-Sant Gervasi
08022 Barcelona
December 19th
SJD Barcelona Children's Hospital
Passeig Sant Joan de Déu 2,
08950, Esplugues de Llobregat
Barcelona
Training options
Direction
With the collaboration of:
Do you need more information?
Write to us and we’ll answer any questions you may have about the program.